Aigen Investment Management LP Takes $990,000 Position in The Allstate Co. (NYSE:ALL)

Aigen Investment Management LP purchased a new position in The Allstate Co. (NYSE:ALL - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 5,221 shares of the insurance provider's stock, valued at approximately $990,000.

Other large investors have also recently made changes to their positions in the company. Northwest Investment Counselors LLC bought a new position in shares of Allstate in the 3rd quarter worth $28,000. Catalyst Capital Advisors LLC purchased a new position in Allstate during the 3rd quarter worth $29,000. Versant Capital Management Inc grew its stake in Allstate by 70.9% during the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider's stock worth $30,000 after buying an additional 78 shares during the last quarter. Family Firm Inc. purchased a new position in Allstate during the 2nd quarter worth $38,000. Finally, MCF Advisors LLC grew its stake in Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider's stock worth $53,000 after buying an additional 84 shares during the last quarter. 76.47% of the stock is owned by institutional investors.

Analyst Ratings Changes

ALL has been the topic of several research analyst reports. Roth Mkm restated a "buy" rating and set a $200.00 target price on shares of Allstate in a research note on Wednesday, August 14th. Bank of America boosted their target price on Allstate from $216.00 to $233.00 and gave the stock a "buy" rating in a research note on Friday, October 18th. Evercore ISI boosted their price target on Allstate from $191.00 to $195.00 and gave the company an "in-line" rating in a research note on Wednesday, October 9th. Piper Sandler boosted their price target on Allstate from $188.00 to $196.00 and gave the company an "overweight" rating in a research note on Friday, August 16th. Finally, Barclays boosted their price target on Allstate from $175.00 to $187.00 and gave the company an "underweight" rating in a research note on Thursday, October 31st. One analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $212.56.

Allstate Trading Down 0.4 %

Allstate stock traded down $0.80 during mid-day trading on Wednesday, hitting $197.30. The company's stock had a trading volume of 1,128,079 shares, compared to its average volume of 1,545,719. The firm has a market capitalization of $52.25 billion, a PE ratio of 12.86, a price-to-earnings-growth ratio of 1.77 and a beta of 0.48. The Allstate Co. has a 1 year low of $129.18 and a 1 year high of $201.00. The company has a current ratio of 0.40, a quick ratio of 0.40 and a debt-to-equity ratio of 0.43. The stock's fifty day moving average is $189.43 and its two-hundred day moving average is $176.25.

Allstate (NYSE:ALL - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. During the same period last year, the business posted $0.81 earnings per share. The company's quarterly revenue was up 14.7% on a year-over-year basis. On average, analysts anticipate that The Allstate Co. will post 16.02 EPS for the current year.

Insider Transactions at Allstate

In other news, insider John E. Dugenske sold 36,367 shares of the firm's stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares in the company, valued at $5,236,922.32. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other news, insider John E. Dugenske sold 36,367 shares of the firm's stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares in the company, valued at $5,236,922.32. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Elizabeth Brady sold 49,481 shares of the stock in a transaction on Friday, August 16th. The shares were sold at an average price of $179.09, for a total value of $8,861,552.29. Following the completion of the sale, the executive vice president now owns 19,163 shares in the company, valued at approximately $3,431,901.67. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 192,530 shares of company stock worth $34,967,665 over the last ninety days. Company insiders own 1.80% of the company's stock.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.